Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI

NCT01893151 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Iguratimod
DRUG: Iguratimod placebo

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.